Insiders Alligator Bioscience AB London S.E.

Equities

0RK9

SE0000767188

Delayed London S.E. Other stock markets 15:52:01 17/11/2021 GMT			5-day change	1st Jan Change
2.508 ^SEK	-66.28%		+123.96%	+303.28%

05-14	Alligator Bioscience Announces Initiation of an Investigator-Initiated Phase 1 Clinical Study of Mitazalimab in Local Advanced Pancreatic Cancer	CI
05-06	Transcript : Alligator Bioscience AB, Q1 2024 Earnings Call, May 06, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alligator Bioscience AB Announces Graham Dixon and Veronica Wallin Not Proposed for Re-Election on Board	04-05	CI
Alligator Bioscience AB Appoints Bertil Brinck as Chairman of the Nomination Committee	11-06	CI
Alligator Bioscience Chief Operating Officer to Resign	17/08/23	MT
Alligator Bioscience AB Announces Resignation of Malin Carlsson as Chief Operating Officer At the End of October	17/08/23	CI
Alligator Bioscience AB Announces Executive Changes	05/07/23	CI
Alligator Bioscience AB Announces Management Changes	14/02/23	CI
Alligator Bioscience Promotes Laura Von Schantz to Chief Technology Officer	13/02/23	CI
Nomination Committee appointed in respect of AGM 2023 in Alligator Bioscience AB	24/10/22	AQ
Alligator Bioscience AB Appoints Sumeet Ambarkhane as Its Chief Medical Officer	07/07/22	CI
Alligator Bioscience Expands Its Board of Directors with the Appointment of Staffan Encrantz and Denise Goode	09/05/22	CI
Alligator Bioscience AB Elects Board of Directors	05/05/22	CI
The Nomination Committee's proposal regarding the Board of Directors ahead of the Annual General Meeting 2022 in Alligator Bioscience AB	11/03/22	AQ
Alligator Bioscience AB Announces Board Appointments	11/03/22	CI
Alligator Bioscience Appoints Sumeet Ambarkhane as Chief Medical Officer	01/02/22	CI
Nomination Committee Appointed in Respect of AGM 2022 in Alligator Bioscience AB	20/01/22	AQ
Alligator Bioscience AB Announces Change in the Composition of Nomination Committee	20/01/22	CI
Nomination Committee appointed in respect of AGM 2022 in Alligator Bioscience AB	03/11/21	AQ
Alligator Bioscience Announces Nomination Committee Appointments	03/11/21	CI
Alligator Bioscience Appoints Julie Silber as New Senior Director of Communications and Investor Relations	16/08/21	CI
Alligator Bioscience AB Announces Executive Changes	01/06/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Alligator Bioscience AB London S.E.

Equities

0RK9

SE0000767188

Insiders

Filters